ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Canine Cancer Screening Market Research Report 2026
Published Date: 2026-02-06
|
Report Code: QYRE-Auto-23Z17950
Home | Market Reports | Pets & Animals| Animal Products & Services| Veterinarians
Global Canine Cancer Screening Market Research Report 2024
BUY CHAPTERS

Global Canine Cancer Screening Market Research Report 2026

Code: QYRE-Auto-23Z17950
Report
2026-02-06
Pages:115
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
IDEXX
Zoetis Inc
PetDx
BioMérieux SA
Antech Diagnostics
VolitionRx Limited
Heska Corporation
Mars Pedtcare
Molecular Diagnostics (MDxHealth)
OncoK9
Oncotect

Canine Cancer Screening Market

The global Canine Cancer Screening market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Canine cancer screening is a process used to detect cancer in dogs at an early stage, often before symptoms become noticeable. Early detection can significantly improve the chances of successful treatment. Screening methods may include blood tests, imaging (such as X-rays or ultrasounds), and physical exams. Recently, there has also been progress in genetic testing and liquid biopsy techniques, which involve detecting cancer-related DNA or biomarkers in a dog's blood sample.
The North American market for Canine Cancer Screening is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Canine Cancer Screening is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Canine Cancer Screening in Veterinary Clinics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Canine Cancer Screening include IDEXX, Mars Pedtcare, Zoetis, PetDx, Molecular Diagnostics (MDxHealth), Biomérieux SA, OncoK9, Antech Diagnostics, VolitionRx Limited, Oncotect, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Canine Cancer Screening market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Canine Cancer Screening. The Canine Cancer Screening market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Canine Cancer Screening market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Canine Cancer Screening manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Canine Cancer Screening Market Report

Report Metric Details
Report Name Canine Cancer Screening Market
Segment by Type
  • Liquid Biopsy (Blood-Based Tests)
  • Tissue Biopsy
  • Genomic Testing
  • Biomarker Tests
Segment by Application
  • Veterinary Clinics
  • Veterinary Hospitals
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company IDEXX, Mars Pedtcare, Zoetis, PetDx, Molecular Diagnostics (MDxHealth), Biomérieux SA, OncoK9, Antech Diagnostics, VolitionRx Limited, Oncotect, Heska Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Canine Cancer Screening companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Canine Cancer Screening Market report?

Ans: The main players in the Canine Cancer Screening Market are IDEXX, Mars Pedtcare, Zoetis, PetDx, Molecular Diagnostics (MDxHealth), Biomérieux SA, OncoK9, Antech Diagnostics, VolitionRx Limited, Oncotect, Heska Corporation

What are the Application segmentation covered in the Canine Cancer Screening Market report?

Ans: The Applications covered in the Canine Cancer Screening Market report are Veterinary Clinics, Veterinary Hospitals, Other

What are the Type segmentation covered in the Canine Cancer Screening Market report?

Ans: The Types covered in the Canine Cancer Screening Market report are Liquid Biopsy (Blood-Based Tests), Tissue Biopsy, Genomic Testing, Biomarker Tests

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Canine Cancer Screening Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Liquid Biopsy (Blood-Based Tests)
1.2.3 Tissue Biopsy
1.2.4 Genomic Testing
1.2.5 Biomarker Tests
1.3 Market by Application
1.3.1 Global Canine Cancer Screening Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Veterinary Clinics
1.3.3 Veterinary Hospitals
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Canine Cancer Screening Market Perspective (2021–2032)
2.2 Global Canine Cancer Screening Growth Trends by Region
2.2.1 Global Canine Cancer Screening Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Canine Cancer Screening Historic Market Size by Region (2021–2026)
2.2.3 Canine Cancer Screening Forecasted Market Size by Region (2027–2032)
2.3 Canine Cancer Screening Market Dynamics
2.3.1 Canine Cancer Screening Industry Trends
2.3.2 Canine Cancer Screening Market Drivers
2.3.3 Canine Cancer Screening Market Challenges
2.3.4 Canine Cancer Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Canine Cancer Screening Players by Revenue
3.1.1 Global Top Canine Cancer Screening Players by Revenue (2021–2026)
3.1.2 Global Canine Cancer Screening Revenue Market Share by Players (2021–2026)
3.2 Global Top Canine Cancer Screening Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Canine Cancer Screening Revenue
3.4 Global Canine Cancer Screening Market Concentration Ratio
3.4.1 Global Canine Cancer Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Canine Cancer Screening Revenue in 2025
3.5 Global Key Players of Canine Cancer Screening Head Offices and Areas Served
3.6 Global Key Players of Canine Cancer Screening, Products and Applications
3.7 Global Key Players of Canine Cancer Screening, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Canine Cancer Screening Breakdown Data by Type
4.1 Global Canine Cancer Screening Historic Market Size by Type (2021–2026)
4.2 Global Canine Cancer Screening Forecasted Market Size by Type (2027–2032)
5 Canine Cancer Screening Breakdown Data by Application
5.1 Global Canine Cancer Screening Historic Market Size by Application (2021–2026)
5.2 Global Canine Cancer Screening Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Canine Cancer Screening Market Size (2021–2032)
6.2 North America Canine Cancer Screening Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Canine Cancer Screening Market Size by Country (2021–2026)
6.4 North America Canine Cancer Screening Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Canine Cancer Screening Market Size (2021–2032)
7.2 Europe Canine Cancer Screening Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Canine Cancer Screening Market Size by Country (2021–2026)
7.4 Europe Canine Cancer Screening Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Canine Cancer Screening Market Size (2021–2032)
8.2 Asia-Pacific Canine Cancer Screening Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Canine Cancer Screening Market Size by Region (2021–2026)
8.4 Asia-Pacific Canine Cancer Screening Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Canine Cancer Screening Market Size (2021–2032)
9.2 Latin America Canine Cancer Screening Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Canine Cancer Screening Market Size by Country (2021–2026)
9.4 Latin America Canine Cancer Screening Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Canine Cancer Screening Market Size (2021–2032)
10.2 Middle East & Africa Canine Cancer Screening Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Canine Cancer Screening Market Size by Country (2021–2026)
10.4 Middle East & Africa Canine Cancer Screening Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IDEXX
11.1.1 IDEXX Company Details
11.1.2 IDEXX Business Overview
11.1.3 IDEXX Canine Cancer Screening Introduction
11.1.4 IDEXX Revenue in Canine Cancer Screening Business (2021–2026)
11.1.5 IDEXX Recent Development
11.2 Mars Pedtcare
11.2.1 Mars Pedtcare Company Details
11.2.2 Mars Pedtcare Business Overview
11.2.3 Mars Pedtcare Canine Cancer Screening Introduction
11.2.4 Mars Pedtcare Revenue in Canine Cancer Screening Business (2021–2026)
11.2.5 Mars Pedtcare Recent Development
11.3 Zoetis
11.3.1 Zoetis Company Details
11.3.2 Zoetis Business Overview
11.3.3 Zoetis Canine Cancer Screening Introduction
11.3.4 Zoetis Revenue in Canine Cancer Screening Business (2021–2026)
11.3.5 Zoetis Recent Development
11.4 PetDx
11.4.1 PetDx Company Details
11.4.2 PetDx Business Overview
11.4.3 PetDx Canine Cancer Screening Introduction
11.4.4 PetDx Revenue in Canine Cancer Screening Business (2021–2026)
11.4.5 PetDx Recent Development
11.5 Molecular Diagnostics (MDxHealth)
11.5.1 Molecular Diagnostics (MDxHealth) Company Details
11.5.2 Molecular Diagnostics (MDxHealth) Business Overview
11.5.3 Molecular Diagnostics (MDxHealth) Canine Cancer Screening Introduction
11.5.4 Molecular Diagnostics (MDxHealth) Revenue in Canine Cancer Screening Business (2021–2026)
11.5.5 Molecular Diagnostics (MDxHealth) Recent Development
11.6 Biomérieux SA
11.6.1 Biomérieux SA Company Details
11.6.2 Biomérieux SA Business Overview
11.6.3 Biomérieux SA Canine Cancer Screening Introduction
11.6.4 Biomérieux SA Revenue in Canine Cancer Screening Business (2021–2026)
11.6.5 Biomérieux SA Recent Development
11.7 OncoK9
11.7.1 OncoK9 Company Details
11.7.2 OncoK9 Business Overview
11.7.3 OncoK9 Canine Cancer Screening Introduction
11.7.4 OncoK9 Revenue in Canine Cancer Screening Business (2021–2026)
11.7.5 OncoK9 Recent Development
11.8 Antech Diagnostics
11.8.1 Antech Diagnostics Company Details
11.8.2 Antech Diagnostics Business Overview
11.8.3 Antech Diagnostics Canine Cancer Screening Introduction
11.8.4 Antech Diagnostics Revenue in Canine Cancer Screening Business (2021–2026)
11.8.5 Antech Diagnostics Recent Development
11.9 VolitionRx Limited
11.9.1 VolitionRx Limited Company Details
11.9.2 VolitionRx Limited Business Overview
11.9.3 VolitionRx Limited Canine Cancer Screening Introduction
11.9.4 VolitionRx Limited Revenue in Canine Cancer Screening Business (2021–2026)
11.9.5 VolitionRx Limited Recent Development
11.10 Oncotect
11.10.1 Oncotect Company Details
11.10.2 Oncotect Business Overview
11.10.3 Oncotect Canine Cancer Screening Introduction
11.10.4 Oncotect Revenue in Canine Cancer Screening Business (2021–2026)
11.10.5 Oncotect Recent Development
11.11 Heska Corporation
11.11.1 Heska Corporation Company Details
11.11.2 Heska Corporation Business Overview
11.11.3 Heska Corporation Canine Cancer Screening Introduction
11.11.4 Heska Corporation Revenue in Canine Cancer Screening Business (2021–2026)
11.11.5 Heska Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
IDEXX
Zoetis Inc
PetDx
BioMérieux SA
Antech Diagnostics
VolitionRx Limited
Heska Corporation
Mars Pedtcare
Molecular Diagnostics (MDxHealth)
OncoK9
Oncotect
List of Tables
 Table 1. Global Canine Cancer Screening Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Liquid Biopsy (Blood-Based Tests)
 Table 3. Key Players of Tissue Biopsy
 Table 4. Key Players of Genomic Testing
 Table 5. Key Players of Biomarker Tests
 Table 6. Global Canine Cancer Screening Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Canine Cancer Screening Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global Canine Cancer Screening Market Size by Region (US$ Million), 2021–2026
 Table 9. Global Canine Cancer Screening Market Share by Region (2021–2026)
 Table 10. Global Canine Cancer Screening Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 11. Global Canine Cancer Screening Market Share by Region (2027–2032)
 Table 12. Canine Cancer Screening Market Trends
 Table 13. Canine Cancer Screening Market Drivers
 Table 14. Canine Cancer Screening Market Challenges
 Table 15. Canine Cancer Screening Market Restraints
 Table 16. Global Canine Cancer Screening Revenue by Players (US$ Million), 2021–2026
 Table 17. Global Canine Cancer Screening Market Share by Players (2021–2026)
 Table 18. Global Top Canine Cancer Screening Players by Tier (Tier 1, Tier 2, and Tier 3), based on Canine Cancer Screening Revenue, 2025
 Table 19. Ranking of Global Top Canine Cancer Screening Companies by Revenue (US$ Million) in 2025
 Table 20. Global 5 Largest Players Market Share by Canine Cancer Screening Revenue (CR5 and HHI), 2021–2026
 Table 21. Global Key Players of Canine Cancer Screening, Headquarters and Area Served
 Table 22. Global Key Players of Canine Cancer Screening, Products and Applications
 Table 23. Global Key Players of Canine Cancer Screening, Date of General Availability (GA)
 Table 24. Mergers and Acquisitions, Expansion Plans
 Table 25. Global Canine Cancer Screening Market Size by Type (US$ Million), 2021–2026
 Table 26. Global Canine Cancer Screening Revenue Market Share by Type (2021–2026)
 Table 27. Global Canine Cancer Screening Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 28. Global Canine Cancer Screening Revenue Market Share by Type (2027–2032)
 Table 29. Global Canine Cancer Screening Market Size by Application (US$ Million), 2021–2026
 Table 30. Global Canine Cancer Screening Revenue Market Share by Application (2021–2026)
 Table 31. Global Canine Cancer Screening Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 32. Global Canine Cancer Screening Revenue Market Share by Application (2027–2032)
 Table 33. North America Canine Cancer Screening Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 34. North America Canine Cancer Screening Market Size by Country (US$ Million), 2021–2026
 Table 35. North America Canine Cancer Screening Market Size by Country (US$ Million), 2027–2032
 Table 36. Europe Canine Cancer Screening Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 37. Europe Canine Cancer Screening Market Size by Country (US$ Million), 2021–2026
 Table 38. Europe Canine Cancer Screening Market Size by Country (US$ Million), 2027–2032
 Table 39. Asia-Pacific Canine Cancer Screening Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 40. Asia-Pacific Canine Cancer Screening Market Size by Region (US$ Million), 2021–2026
 Table 41. Asia-Pacific Canine Cancer Screening Market Size by Region (US$ Million), 2027–2032
 Table 42. Latin America Canine Cancer Screening Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Latin America Canine Cancer Screening Market Size by Country (US$ Million), 2021–2026
 Table 44. Latin America Canine Cancer Screening Market Size by Country (US$ Million), 2027–2032
 Table 45. Middle East & Africa Canine Cancer Screening Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Middle East & Africa Canine Cancer Screening Market Size by Country (US$ Million), 2021–2026
 Table 47. Middle East & Africa Canine Cancer Screening Market Size by Country (US$ Million), 2027–2032
 Table 48. IDEXX Company Details
 Table 49. IDEXX Business Overview
 Table 50. IDEXX Canine Cancer Screening Product
 Table 51. IDEXX Revenue in Canine Cancer Screening Business (US$ Million), 2021–2026
 Table 52. IDEXX Recent Development
 Table 53. Mars Pedtcare Company Details
 Table 54. Mars Pedtcare Business Overview
 Table 55. Mars Pedtcare Canine Cancer Screening Product
 Table 56. Mars Pedtcare Revenue in Canine Cancer Screening Business (US$ Million), 2021–2026
 Table 57. Mars Pedtcare Recent Development
 Table 58. Zoetis Company Details
 Table 59. Zoetis Business Overview
 Table 60. Zoetis Canine Cancer Screening Product
 Table 61. Zoetis Revenue in Canine Cancer Screening Business (US$ Million), 2021–2026
 Table 62. Zoetis Recent Development
 Table 63. PetDx Company Details
 Table 64. PetDx Business Overview
 Table 65. PetDx Canine Cancer Screening Product
 Table 66. PetDx Revenue in Canine Cancer Screening Business (US$ Million), 2021–2026
 Table 67. PetDx Recent Development
 Table 68. Molecular Diagnostics (MDxHealth) Company Details
 Table 69. Molecular Diagnostics (MDxHealth) Business Overview
 Table 70. Molecular Diagnostics (MDxHealth) Canine Cancer Screening Product
 Table 71. Molecular Diagnostics (MDxHealth) Revenue in Canine Cancer Screening Business (US$ Million), 2021–2026
 Table 72. Molecular Diagnostics (MDxHealth) Recent Development
 Table 73. Biomérieux SA Company Details
 Table 74. Biomérieux SA Business Overview
 Table 75. Biomérieux SA Canine Cancer Screening Product
 Table 76. Biomérieux SA Revenue in Canine Cancer Screening Business (US$ Million), 2021–2026
 Table 77. Biomérieux SA Recent Development
 Table 78. OncoK9 Company Details
 Table 79. OncoK9 Business Overview
 Table 80. OncoK9 Canine Cancer Screening Product
 Table 81. OncoK9 Revenue in Canine Cancer Screening Business (US$ Million), 2021–2026
 Table 82. OncoK9 Recent Development
 Table 83. Antech Diagnostics Company Details
 Table 84. Antech Diagnostics Business Overview
 Table 85. Antech Diagnostics Canine Cancer Screening Product
 Table 86. Antech Diagnostics Revenue in Canine Cancer Screening Business (US$ Million), 2021–2026
 Table 87. Antech Diagnostics Recent Development
 Table 88. VolitionRx Limited Company Details
 Table 89. VolitionRx Limited Business Overview
 Table 90. VolitionRx Limited Canine Cancer Screening Product
 Table 91. VolitionRx Limited Revenue in Canine Cancer Screening Business (US$ Million), 2021–2026
 Table 92. VolitionRx Limited Recent Development
 Table 93. Oncotect Company Details
 Table 94. Oncotect Business Overview
 Table 95. Oncotect Canine Cancer Screening Product
 Table 96. Oncotect Revenue in Canine Cancer Screening Business (US$ Million), 2021–2026
 Table 97. Oncotect Recent Development
 Table 98. Heska Corporation Company Details
 Table 99. Heska Corporation Business Overview
 Table 100. Heska Corporation Canine Cancer Screening Product
 Table 101. Heska Corporation Revenue in Canine Cancer Screening Business (US$ Million), 2021–2026
 Table 102. Heska Corporation Recent Development
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Canine Cancer Screening Picture
 Figure 2. Global Canine Cancer Screening Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Canine Cancer Screening Market Share by Type: 2025 vs 2032
 Figure 4. Liquid Biopsy (Blood-Based Tests) Features
 Figure 5. Tissue Biopsy Features
 Figure 6. Genomic Testing Features
 Figure 7. Biomarker Tests Features
 Figure 8. Global Canine Cancer Screening Market Size by Application (US$ Million), 2021–2032
 Figure 9. Global Canine Cancer Screening Market Share by Application: 2025 vs 2032
 Figure 10. Veterinary Clinics Case Studies
 Figure 11. Veterinary Hospitals Case Studies
 Figure 12. Other Case Studies
 Figure 13. Canine Cancer Screening Report Years Considered
 Figure 14. Global Canine Cancer Screening Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 15. Global Canine Cancer Screening Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global Canine Cancer Screening Market Share by Region: 2025 vs 2032
 Figure 17. Global Canine Cancer Screening Market Share by Players in 2025
 Figure 18. Global Canine Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 19. The Top 10 and 5 Players Market Share by Canine Cancer Screening Revenue in 2025
 Figure 20. North America Canine Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. North America Canine Cancer Screening Market Share by Country (2021–2032)
 Figure 22. United States Canine Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Canada Canine Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Canine Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Europe Canine Cancer Screening Market Share by Country (2021–2032)
 Figure 26. Germany Canine Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. France Canine Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. U.K. Canine Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Italy Canine Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Russia Canine Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Ireland Canine Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Canine Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Asia-Pacific Canine Cancer Screening Market Share by Region (2021–2032)
 Figure 34. China Canine Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Japan Canine Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. South Korea Canine Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Southeast Asia Canine Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. India Canine Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Australia & New Zealand Canine Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Canine Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Latin America Canine Cancer Screening Market Share by Country (2021–2032)
 Figure 42. Mexico Canine Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Brazil Canine Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Canine Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Middle East & Africa Canine Cancer Screening Market Share by Country (2021–2032)
 Figure 46. Israel Canine Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Saudi Arabia Canine Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. UAE Canine Cancer Screening Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. IDEXX Revenue Growth Rate in Canine Cancer Screening Business (2021–2026)
 Figure 50. Mars Pedtcare Revenue Growth Rate in Canine Cancer Screening Business (2021–2026)
 Figure 51. Zoetis Revenue Growth Rate in Canine Cancer Screening Business (2021–2026)
 Figure 52. PetDx Revenue Growth Rate in Canine Cancer Screening Business (2021–2026)
 Figure 53. Molecular Diagnostics (MDxHealth) Revenue Growth Rate in Canine Cancer Screening Business (2021–2026)
 Figure 54. Biomérieux SA Revenue Growth Rate in Canine Cancer Screening Business (2021–2026)
 Figure 55. OncoK9 Revenue Growth Rate in Canine Cancer Screening Business (2021–2026)
 Figure 56. Antech Diagnostics Revenue Growth Rate in Canine Cancer Screening Business (2021–2026)
 Figure 57. VolitionRx Limited Revenue Growth Rate in Canine Cancer Screening Business (2021–2026)
 Figure 58. Oncotect Revenue Growth Rate in Canine Cancer Screening Business (2021–2026)
 Figure 59. Heska Corporation Revenue Growth Rate in Canine Cancer Screening Business (2021–2026)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Canine Tumor Screening Market Research Report 2024
Global Pet Health Screening Market Research Report 2024
Global Canine Cancer Detection Market Research Report 2024
Global Canine Biopsy Services Market Research Report 2025
Global Canine Liquid Biopsy Market Research Report 2024
Global Canine Fluid Biopsy Market Research Report 2025
Global Mobile Cancer Screening Devices Market Insights Forecast to 2030
Global DNA Testing for Pets Market Research Report 2024
Global Dog DNA Testing Service Market Research Report 2024
Global Colorectal Cancer Screening Test Market Research Report 2024
Global Pets Infectious Disease Screening Market Research Report 2025
Pets Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dog Full Genetic Testing Service Market Research Report 2025
Global Pet Diagnostic Imaging Market Research Report 2024
Global Breast Cancer Testing Market Insights Forecast to 2030
Global Tumor Detection Services Market Research Report 2024
Global Cancer Early Detection Market Research Report 2025
Cancer Early Detection and Screening Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pet Dog DNA Test Market Research Report 2025
Global Pet Biopsy Services Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions